The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases

A Sharif, J Mamo, V Lam, H Al-Salami, A Mooranian, GF Watts, R Clarnette, G Luna, R Takechi

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


Neurodegenerative disorders present complex pathologies characterized by various interconnected factors, including the aggregation of misfolded proteins, oxidative stress, neuroinflammation and compromised blood-brain barrier (BBB) integrity. Addressing such multifaceted pathways necessitates the development of multi-target therapeutic strategies. Emerging research indicates that probucol, a historic lipid-lowering medication, offers substantial potential in the realm of neurodegenerative disease prevention and treatment. Preclinical investigations have unveiled multifaceted cellular effects of probucol, showcasing its remarkable antioxidative and anti-inflammatory properties, its ability to fortify the BBB and its direct influence on neural preservation and adaptability. These diverse effects collectively translate into enhancements in both motor and cognitive functions. This review provides a comprehensive overview of recent findings highlighting the efficacy of probucol and probucol-related compounds in the context of various neurodegenerative conditions, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and cognitive impairment associated with diabetes.
Original languageEnglish
Article number6
Number of pages12
JournalTranslational Neurodegeneration
Issue number1
Early online date22 Jan 2024
Publication statusPublished - 2024


Dive into the research topics of 'The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases'. Together they form a unique fingerprint.

Cite this